VP, Digital Business Development
Jeremy Sohn joined Novartis, in November 2015, as VP, Head of Digital Business Development & Licensing supporting Novartis’ Digital Medicines program cross-divisionally. Since February 2016, Jeremy has also served as Global Head of Digital Development, Novartis Pharma.
Jeremy is a serial software entrepreneur with more than 15 years of experience founding, managing and advising both healthcare and technology companies. Prior to Novartis, Jeremy was Managing Director & Operating Partner at MPM Capital where he led the firm’s digital health investment strategy and partnership with Novartis. At MPM, Jeremy founded two companies, CentrosHealth (a mobile, patient-engagement platform designed to improve the patient experience during clinical trials, acquired by Clinical Ink) and TriNetX (a federated network of clinical data warehouses that optimizes clinical trial protocol design and patient recruitment). In 2011, Jeremy co-founded GrapeVine, a transformative software company that uses data aggregation, predictive analytics and targeted marketing, and business intelligence tools to improve how organizations connect with the individuals based on their interests, needs, and friends’ networks. From 2007-2011, Jeremy was the Chief Operating Officer and Vice President of Strategy & Corporate Development for North Plains Systems, where he helped lead the company’s growth and eventual sale to Accel-KKR. In 2000, he co-founded an operating system and software-storage company, Wasabi Systems, and led the company’s worldwide Business Development activities.
Jeremy graduated from Princeton University’s Woodrow Wilson School of Public and International Affairs, with a focus on biotechnology and medical policy.